Share

April 10, 2018; 90 (15 Supplement) April 22, 2018

Design of the First-in-Human Study of IONIS-MAPTRx, a Tau-lowering Antisense Oligonucleotide, in Patients With Alzheimer Disease (S2.006)

Laurence Mignon, Holly Kordasiewicz, Roger Lane, Anne Smith, Timothy Miller, Padma Narayanan, Eric Swayze, Daniel Norris, Bethany Fitzsimmons, Frank Bennett
First published April 9, 2018,
Citation
Permissions

Make Comment

See Comments

Downloads
0

Share

Article Information

vol. 90 no. 15 Supplement S2.006
Published By: 
Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology
Print ISSN: 
0028-3878
Online ISSN: 
1526-632X
History: 
  • First Published April 9, 2018.
Copyright & Usage: 
© 2018

Author Disclosures

    1. Laurence Mignon1,
    2. Holly Kordasiewicz1,
    3. Roger Lane1,
    4. Anne Smith1,
    5. Timothy Miller2,
    6. Padma Narayanan1,
    7. Eric Swayze1,
    8. Daniel Norris1,
    9. Bethany Fitzsimmons1 and
    10. Frank Bennett1
  1. Laurence Mignon1,
  2. Holly Kordasiewicz1,
  3. Roger Lane1,
  4. Anne Smith1,
  5. Timothy Miller2,
  6. Padma Narayanan1,
  7. Eric Swayze1,
  8. Daniel Norris1,
  9. Bethany Fitzsimmons1 and
  10. Frank Bennett1
  1. 1Ionis Pharmaceuticals, Inc Carlsbad CA United States
  2. 2Washington University Saint Louis MO United States

Article usage

Article usage: April 2018 to April 2022

AbstractFullPdfSource
Apr 201813800Highwire
May 20184500Highwire
Jun 20185700Highwire
Jul 20184600Highwire
Aug 20183500Highwire
Sep 20184100Highwire
Oct 20188100Highwire
Nov 20186800Highwire
Dec 20183800Highwire
Jan 20196000Highwire
Feb 20196400Highwire
Mar 201912700Highwire
Apr 20198100Highwire
May 20199400Highwire
Jun 20197200Highwire
Jul 20198200Highwire
Aug 20196100Highwire
Sep 20195000Highwire
Oct 20196700Highwire
Nov 20194500Highwire
Dec 20196500Highwire
Jan 20208700Highwire
Feb 20208500Highwire
Mar 20205900Highwire
Apr 20205300Highwire
May 20208100Highwire
Jun 20204800Highwire
Jul 20202600Highwire
Aug 20202900Highwire
Sep 20203600Highwire
Oct 20203800Highwire
Nov 20205000Highwire
Dec 20205800Highwire
Jan 20213700Highwire
Feb 20215400Highwire
Mar 20215100Highwire
Apr 20215300Highwire
May 20215300Highwire
Jun 20215800Highwire
Jul 20217200Highwire
Aug 20216000Highwire
Sep 20213000Highwire
Oct 20213200Highwire
Nov 20214400Highwire
Dec 20213100Highwire
Jan 20224800Highwire
Feb 20224500Highwire
Mar 20225300Highwire
Apr 20224300Highwire

Disputes & Debates: Rapid online correspondence

No comments have been published for this article.
Comment

REQUIREMENTS

If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
Advertisement

Related Articles

  • No related articles found.

Alert Me